A Look At Insmed (INSM) Valuation After Recent Share Price Weakness And Brensocatib Launch Expectations

Simply Wall St. · 2026-06-02T12:05:35Z

ATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri

Pharmaceutical Technology · 2026-06-02T02:08:26Z

NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million

Motley Fool · 2026-05-30T13:36:17Z

Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%

Motley Fool · 2026-05-30T00:47:22Z

Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More

Motley Fool · 2026-05-30T00:41:49Z

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Investing.com · 2026-05-28T20:27:17Z

JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms

Investing.com · 2026-05-20T19:29:36Z

Competitive Pressures Prompt Truist to Cut Target on Insmed (INSM)

Insider Monkey · 2026-05-20T10:15:10Z

Assessing Insmed (INSM) Valuation After Recent Share Price Pullback And Strong Multi Year Returns

Simply Wall St. · 2026-05-19T09:12:40Z

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus

MarketBeat · 2026-05-18T07:03:32Z